SRPT logo

Sarepta Therapeutics, Inc. (SRPT) Operating Expenses

Annual Operating Expenses:

$1.36B+$3.98M(+0.29%)
December 31, 2024

Summary

  • As of today, SRPT annual total operating expenses is $1.36 billion, with the most recent change of +$3.98 million (+0.29%) on December 31, 2024.
  • During the last 3 years, SRPT annual operating expenses has risen by +$310.25 million (+29.42%).
  • SRPT annual operating expenses is now at all-time high.

Performance

SRPT Operating Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSRPTincome statement metrics

Quarterly Operating Expenses:

$293.01M-$39.11M(-11.77%)
September 30, 2025

Summary

  • As of today, SRPT quarterly total operating expenses is $293.01 million, with the most recent change of -$39.11 million (-11.77%) on September 30, 2025.
  • Over the past year, SRPT quarterly operating expenses has dropped by -$50.47 million (-14.69%).
  • SRPT quarterly operating expenses is now -67.36% below its all-time high of $897.70 million, reached on March 31, 2025.

Performance

SRPT Quarterly Operating Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSRPTincome statement metrics

Operating Expenses Formula

Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses

SRPT Operating Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+0.3%-14.7%
3Y3 Years+29.4%-5.8%
5Y5 Years+61.2%+13.0%

SRPT Operating Expenses Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Yearat high+29.4%-67.4%at low
5Y5-Yearat high+61.2%-67.4%+54.3%
All-TimeAll-Timeat high>+9999.0%-67.4%>+9999.0%

SRPT Operating Expenses History

DateAnnualQuarterly
Sep 2025
-
$293.01M(-11.8%)
Jun 2025
-
$332.12M(-63.0%)
Mar 2025
-
$897.70M(+153.6%)
Dec 2024
$1.36B(+0.3%)
$353.97M(+3.1%)
Sep 2024
-
$343.48M(+10.7%)
Jun 2024
-
$310.37M(-2.8%)
Mar 2024
-
$319.26M(+0.8%)
Dec 2023
$1.36B(+2.4%)
$316.61M(+3.9%)
Sep 2023
-
$304.70M(-12.9%)
Jun 2023
-
$349.84M(+1.3%)
Mar 2023
-
$345.27M(+6.6%)
Dec 2022
$1.33B(+26.0%)
$323.91M(+4.2%)
Sep 2022
-
$310.97M(-21.7%)
Jun 2022
-
$396.94M(+55.3%)
Mar 2022
-
$255.55M(-3.7%)
Dec 2021
$1.05B(+1.3%)
$265.38M(+39.7%)
Sep 2021
-
$189.93M(-37.5%)
Jun 2021
-
$303.70M(+17.9%)
Mar 2021
-
$257.52M(-10.0%)
Dec 2020
$1.04B(+23.0%)
$286.06M(+10.3%)
Sep 2020
-
$259.36M(+1.4%)
Jun 2020
-
$255.90M(+20.4%)
Mar 2020
-
$212.55M(-30.2%)
Dec 2019
$846.57M(+38.7%)
$304.37M(+45.4%)
Sep 2019
-
$209.38M(+15.9%)
Jun 2019
-
$180.66M(+19.5%)
Mar 2019
-
$151.12M(-26.9%)
Dec 2018
$610.47M(+110.2%)
$206.63M(+48.0%)
Sep 2018
-
$139.63M(-18.9%)
Jun 2018
-
$172.23M(+92.3%)
Mar 2018
-
$89.55M(+17.2%)
Dec 2017
$290.44M(+7.8%)
$76.42M(+22.5%)
Sep 2017
-
$62.40M(-28.6%)
Jun 2017
-
$87.41M(+63.5%)
Mar 2017
-
$53.46M(-41.9%)
Dec 2016
$269.50M(+21.7%)
$92.02M(+69.8%)
Sep 2016
-
$54.20M(-9.7%)
Jun 2016
-
$60.00M(+3.9%)
Mar 2016
-
$57.77M(-10.4%)
Dec 2015
$221.44M(+54.3%)
$64.45M(+27.8%)
Sep 2015
-
$50.45M(+23.6%)
Jun 2015
-
$40.82M(-20.4%)
Mar 2015
-
$51.30M(+14.7%)
Dec 2014
$143.55M(+37.4%)
$44.72M(+32.8%)
Sep 2014
-
$33.67M(+11.2%)
Jun 2014
-
$30.27M(+23.4%)
Mar 2014
-
$24.52M(-25.1%)
Dec 2013
$104.50M(+55.9%)
$32.75M(+31.6%)
Sep 2013
-
$24.88M(+45.6%)
Jun 2013
-
$17.09M(+14.3%)
Mar 2013
-
$14.95M(+44.3%)
Dec 2012
$67.03M(-19.2%)
$10.37M(+50.1%)
Sep 2012
-
$6.91M(+136.9%)
Jun 2012
-
$2.92M(-57.6%)
Mar 2012
-
$6.87M(+109.1%)
Dec 2011
$82.92M
$3.29M(+12.9%)
Sep 2011
-
$2.91M(-21.5%)
Jun 2011
-
$3.71M(-22.5%)
DateAnnualQuarterly
Mar 2011
-
$4.79M(+175.9%)
Dec 2010
$50.35M(+52.2%)
$1.74M(-85.2%)
Sep 2010
-
$11.74M(+38.0%)
Jun 2010
-
$8.51M(-0.9%)
Mar 2010
-
$8.59M(+117.3%)
Dec 2009
$33.09M(-14.7%)
$3.95M(+35.2%)
Sep 2009
-
$2.92M(-42.3%)
Jun 2009
-
$5.07M(+42.1%)
Mar 2009
-
$3.56M(+23.2%)
Dec 2008
$38.80M(-12.0%)
$2.89M(-40.7%)
Sep 2008
-
$4.88M(0.0%)
Jun 2008
-
$4.88M(+146.1%)
Mar 2008
-
$1.98M(-65.0%)
Dec 2007
$44.09M(+33.2%)
$5.67M(+267.0%)
Sep 2007
-
$1.54M(-23.9%)
Jun 2007
-
$2.03M(-58.0%)
Mar 2007
-
$4.84M(+134.0%)
Dec 2006
$33.10M(+48.4%)
$2.07M(+53.5%)
Sep 2006
-
$1.35M(-11.1%)
Jun 2006
-
$1.52M(-46.3%)
Mar 2006
-
$2.82M(+100.2%)
Dec 2005
$22.30M(-12.5%)
$1.41M(+33.9%)
Sep 2005
-
$1.05M(-17.3%)
Jun 2005
-
$1.27M(-77.1%)
Mar 2005
-
$5.55M(+12.3%)
Dec 2004
$25.47M(+28.4%)
$4.94M(+411.8%)
Sep 2004
-
$964.70K(-13.6%)
Jun 2004
-
$1.12M(-85.6%)
Mar 2004
-
$7.75M(+13.4%)
Dec 2003
$19.84M(-24.2%)
$6.84M(+338.3%)
Sep 2003
-
$1.56M(+32.5%)
Jun 2003
-
$1.18M(+26.1%)
Mar 2003
-
$933.40K(-77.5%)
Dec 2002
$26.18M(+62.5%)
$4.15M(+311.5%)
Sep 2002
-
$1.01M(+12.6%)
Jun 2002
-
$896.00K(-17.4%)
Mar 2002
-
$1.08M(+23.5%)
Dec 2001
$16.11M(+34.7%)
-
Sep 2001
-
$878.00K(+23.7%)
Jun 2001
-
$709.50K(-26.4%)
Mar 2001
-
$964.10K(+72.8%)
Dec 2000
$11.96M(+37.4%)
-
Sep 2000
-
$557.90K(+13.8%)
Jun 2000
-
$490.20K(+12.4%)
Mar 2000
-
$436.10K(+2.4%)
Dec 1999
$8.70M(+7.4%)
-
Sep 1999
-
$425.70K(+1.6%)
Jun 1999
-
$418.90K(+0.3%)
Mar 1999
-
$417.60K(+13.9%)
Dec 1998
$8.10M(+80.0%)
-
Sep 1998
-
$366.60K(-27.4%)
Jun 1998
-
$505.00K(+64.5%)
Mar 1998
-
$307.00K(-74.4%)
Dec 1997
$4.50M(+60.7%)
$1.20M(+20.0%)
Sep 1997
-
$1.00M(-33.3%)
Jun 1997
-
$1.50M(+87.5%)
Mar 1997
-
$800.00K
Dec 1996
$2.80M
-

FAQ

  • What is Sarepta Therapeutics, Inc. annual total operating expenses?
  • What is the all-time high annual operating expenses for Sarepta Therapeutics, Inc.?
  • What is Sarepta Therapeutics, Inc. annual operating expenses year-on-year change?
  • What is Sarepta Therapeutics, Inc. quarterly total operating expenses?
  • What is the all-time high quarterly operating expenses for Sarepta Therapeutics, Inc.?
  • What is Sarepta Therapeutics, Inc. quarterly operating expenses year-on-year change?

What is Sarepta Therapeutics, Inc. annual total operating expenses?

The current annual operating expenses of SRPT is $1.36B

What is the all-time high annual operating expenses for Sarepta Therapeutics, Inc.?

Sarepta Therapeutics, Inc. all-time high annual total operating expenses is $1.36B

What is Sarepta Therapeutics, Inc. annual operating expenses year-on-year change?

Over the past year, SRPT annual total operating expenses has changed by +$3.98M (+0.29%)

What is Sarepta Therapeutics, Inc. quarterly total operating expenses?

The current quarterly operating expenses of SRPT is $293.01M

What is the all-time high quarterly operating expenses for Sarepta Therapeutics, Inc.?

Sarepta Therapeutics, Inc. all-time high quarterly total operating expenses is $897.70M

What is Sarepta Therapeutics, Inc. quarterly operating expenses year-on-year change?

Over the past year, SRPT quarterly total operating expenses has changed by -$50.47M (-14.69%)
On this page